ChemoCentryx, Inc. Additional Paid in Capital
ChemoCentryx, Inc. had Additional Paid in Capital of $328.44 million as of 2014-12-31, per its 10-K filed 2015-03-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2015-03-13
- 2014-12-31: Additional Paid in Capital $328.44M.
- 2014-09-30: Additional Paid in Capital $326.10M.
- 2014-06-30: Additional Paid in Capital $324.04M.
- 2014-03-31: Additional Paid in Capital $321.50M.
| Period end | Additional Paid in Capital |
|---|---|
| 2014-12-31 | $328.44M 10-K · filed 2015-03-13 |
| 2014-09-30 | $326.10M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $324.04M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $321.50M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $318.10M 10-K · filed 2015-03-13 |
| 2013-09-30 | $316.47M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $314.58M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $247.65M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $244.51M 10-K · filed 2014-03-14 |
| 2012-09-30 | $242.33M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $240.69M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $239.76M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $170.29M 10-K · filed 2013-03-14 |